GRUPO 1.- ENFERMEDAD CARDIOVASCULAR:

ALTA INTENSIDAD SI EDAD < 75 A.

MODERADA INTENSIDAD SI > 75 A.

GRUPO 2.- PACIENTES CON LDL > 190 mg / ml

ALTA INTENSIDAD

GRUPO 3.- DIABETICOS DE 40-75 a. LDL 70-189

ALTA INTENSIDAD SI RCV > 7,5 %

INTENSIDAD MODERADA SI RCV < 7,5 %

GRUPO 4.-PACIENTES LDL >70 mg% Y RCV >7,5 %

ALTA INTENSIDAD CON RCV > 7,5 %

MODERADA INTENSIDAD 5-7,5 %

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce

Atherosclerotic Cardiovascular Risk in Adults

A Report of the American College of Cardiology/American Heart Association Task Force on

Practice Guidelines (November 2013)

Trat. Alta-Intensidad con Estatinas

Atorvastatin (40†)–80 mg

Rosuvastatin 20 (40) mg

Trat. Moderada Intensidad Estatinas

Atorvastatin 10 (20) mg

Rosuvastatin (5) 10 mg

Simvastatin 20–40 mg‡

Pravastatin 40 (80) mg

Lovastatin 40 mg

Fluvastatin XL 80 mg

Fluvastatin 40 mg bid

Pitavastatin 2–4 mg

In an article published November 18, 2013 in the New York Times , two physicians testing the accuracy of the new risk calculator developed by the American College of Cardiology(ACC) and American Heart Association (AHA) found that it vastly overestimated patient risk. Drs Paul Ridker and Nancy Cook (Brigham and Women's Hospital, Boston, MA) calculated the 10-year risk of cardiovascular events in three large-scale primary prevention cohorts—the Women's Health Study(WHS), the Physicians' Health Study (PHS), and theWomen's Health Initiative

Observational Study (WHI-OS)—”SOBRESTIMA EL RCV ENTRE EL 75% AL 150%”

European Guidelines on cardiovascular disease prevention in clinical

practice (version 2012)

European Heart Journal Advance Access published May 3, 2012